Who Paid My Doc
Daniel Jones
Molecular Genetic Pathology Columbus, OH Medical Doctor
NPI 1205884459 CMS profile 824536
2001 Polaris Pkwy, Columbus, OH 43240
General payments
$1,600
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$351,395
Through program year 2023, Daniel Jones of Columbus, OH is reported in the CMS Open Payments database as having received $1,600 across 1 general payment and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $351,395 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $1,600 | 1 |
Beside peers
- Daniel Jones
- Molecular Genetic Pathology median
- Middle half of Molecular Genetic Pathology
- National median
In program year 2025, general payments to Daniel Jones were reported at $0. Among 27 Molecular Genetic Pathology profiles paid that year, the median was $225 and the middle half received between $91 and $3,596.
Show as a table
| Year | Daniel Jones | Molecular Genetic Pathology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $131 | $38–$1,524 | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $0 | $900 | $25–$1,899 | $132 |
| 2022 | $0 | $136 | $28–$4,738 | $149 |
| 2023 | $1,600 | $139 | $48–$3,150 | $160 |
| 2024 | $0 | $1,077 | $71–$2,833 | $164 |
| 2025 | $0 | $225 | $91–$3,596 | $169 |
Breakdown
Billing to Medicare
Part B · data year 2024 · 21 billing codesPaid by Medicare
$52,562
Medicare patients
604
Services billed
1,763
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 47% | |
| Cancer | 39% | |
| Ischemic heart disease | 37% | |
| Diabetes | 33% | |
| Chronic kidney disease | 33% | |
| Depression | 28% | |
| Atrial fibrillation | 26% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Molecular Genetic Pathology in Ohio
Related records
Molecular Genetic Pathology in Ohio
Practitioners in the same specialty and state, ranked by reported value.
All Molecular Genetic Pathology
Everyone recorded under this specialty, nationwide.
Doctors in Ohio
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.